Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2007 3
2008 1
2010 1
2012 1
2013 2
2014 1
2015 5
2016 3
2017 3
2019 4
2021 2
2022 1
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Innate-Adaptive Immune Crosstalk.
Shanker A, Thounaojam MC, Mishra MK, Dikov MM, Uzhachenko RV. Shanker A, et al. Among authors: uzhachenko rv. J Immunol Res. 2015;2015:982465. doi: 10.1155/2015/982465. Epub 2015 Nov 4. J Immunol Res. 2015. PMID: 26618182 Free PMC article. No abstract available.
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression.
Evans JV, Suman S, Goruganthu MUL, Tchekneva EE, Guan S, Arasada RR, Antonucci A, Piao L, Ilgisonis I, Bobko AA, Driesschaert B, Uzhachenko RV, Hoyd R, Samouilov A, Amann J, Wu R, Wei L, Pallerla A, Ryzhov SV, Feoktistov I, Park KP, Kikuchi T, Castro J, Ivanova AV, Kanagasabai T, Owen DH, Spakowicz DJ, Zweier JL, Carbone DP, Novitskiy SV, Khramtsov VV, Shanker A, Dikov MM. Evans JV, et al. Among authors: uzhachenko rv. J Natl Cancer Inst. 2023 Nov 8;115(11):1404-1419. doi: 10.1093/jnci/djad091. J Natl Cancer Inst. 2023. PMID: 37195421 Free PMC article.
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses.
Kumar A, Ramani V, Bharti V, de Lima Bellan D, Saleh N, Uzhachenko R, Shen C, Arteaga C, Richmond A, Reddy SM, Vilgelm A. Kumar A, et al. Among authors: uzhachenko r. J Immunother Cancer. 2023 May;11(5):e006019. doi: 10.1136/jitc-2022-006019. J Immunother Cancer. 2023. PMID: 37230537 Free PMC article.
30 results